Horwich A, Bloom H J
Int J Radiat Oncol Biol Phys. 1985 Jun;11(6):1067-79. doi: 10.1016/0360-3016(85)90052-5.
A retrospective study was performed of 30 patients with optic gliomas referred to the Royal Marsden Hospital between 1951 and 1981. Twenty-nine of these had progressive disease, and were treated with radiotherapy. At presentation 12 (41%) had visual deficit to the extent of at least one blind eye. Visual acuity improved following treatment in 10 (43%) of 23 evaluable patients, was stable in 11 (48%) and deteriorated in 2 (9%). There was increase in visual fields in 4 (18%) of 22 evaluable patients, and no change in the remaining 18 (82%). Overall 26/29 (90%) of irradiated patients remained free from disease progression at a median follow-up period of 10 years. The probability of survival was 100% at five years following radiotherapy, and 93% at 10 years and also at 15 years. In view of the substantial morbidity and mortality in reported series, and the tendency for referral of more serious cases to a radiotherapy center, we conclude from our results that radiotherapy is effective in preventing progression of optic glioma, and that treatment early in the course of the disease is indicated to minimize the associated visual deficit.
对1951年至1981年间转诊至皇家马斯登医院的30例视神经胶质瘤患者进行了一项回顾性研究。其中29例患有进展性疾病,并接受了放射治疗。就诊时,12例(41%)存在至少一只眼失明程度的视力缺陷。在23例可评估患者中,10例(43%)治疗后视力改善,11例(48%)稳定,2例(9%)恶化。在22例可评估患者中,4例(18%)视野扩大,其余18例(82%)无变化。总体而言,29例接受放疗的患者中有26例(90%)在中位随访期10年时仍无疾病进展。放疗后5年生存率为100%,10年和15年时均为93%。鉴于报告系列中的显著发病率和死亡率,以及更严重病例转诊至放疗中心的趋势,我们从研究结果中得出结论,放疗可有效预防视神经胶质瘤进展,且在疾病早期进行治疗有助于将相关视力缺陷降至最低。